B · Normal
[The concept of innovative drugs rebounded in shock, and Hokuriku Pharmaceutical rose by more than 10%] On September 22, the concept of innovative drugs rebounded in shock, and Beiku Pharmaceutical rose by more than 10%. Previously, Harbin Pharmaceutical Co., Ltd. and Xinhua Pharmaceutical hit the daily limit, and Ruikang Pharmaceutical, Baihua Pharmaceutical, Tailong Pharmaceutical, Jiankai Technology, and Baike Biologics followed suit. On the news, overnight U.S. "cancer vaccine" bull stock Moderna closed up 12.27% on Monday, nearly returning to the year's high hit after the "cancer vaccine" results were released on August 19.
Live broadcast 🕐 2026-09-22 09:52
#vaccine #Live broadcast #Innovative drugs
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

[Analysis of listed stocks on September 22: The promotion rate of listed stocks 09-22 16:11 [Analysis of daily limit on September 22] On September 22, a total of 62 stocks 09-22 15:21 [Review: The GEM index rose slightly after rising, and AI application concept st 09-22 15:02 [The turnover of the Shanghai and Shenzhen stock markets exceeded 2 trillion, an 09-22 14:47 [The three major indexes all turned green] On September 22, the indexes rose and 09-22 14:32 [Main Fund Monitoring: The net outflow of the communications sector exceeds 3.6 09-22 14:20

Comments

0/500
Captcha (click to refresh)
No comments yet